BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Anna Kramvis, Michael C. Kew. Epidemiology of hepatitis B virus in Africa, its genotypes and clinical associations of genotypesHepatology Research 2007; 37(s1): S9 doi: 10.1111/j.1872-034X.2007.00098.x
2
Lior Sagi, Sharon Baum, Nancy Agmon-Levin, Yaniv Sherer, Bat Sheva Porat Katz, Ori Barzilai, Maya Ram, Nicola Bizzaro, Marielle SanMarco, Henri Trau, Yehuda Shoenfeld. Autoimmune bullous diseasesAutoimmunity Reviews 2011; 10(9): 527 doi: 10.1016/j.autrev.2011.04.003
3
Jian-Jun Zhang, Yu-Chen Fan, Ze-Hua Zhao, Yang Yang, Cheng-Yun Dou, Shuai Gao, Kai Wang. Prognoses of patients with acute-on-chronic hepatitis B liver failure are closely associated with altered SOCS1 mRNA expression and cytokine production following glucocorticoid treatmentCellular & Molecular Immunology 2014; 11(4): 396 doi: 10.1038/cmi.2014.23
4
Keiichi Fujiwara, Shin Yasui, Osamu Yokosuka. Corticosteroid and nucleoside analogue for hepatitis B virus-related acute liver failureWorld Journal of Gastroenterology 2015; 21(36): 10485-10486 doi: 10.3748/wjg.v21.i36.10485
5
Yu-Ming Wang, Ke Li, Xiao-Guang Dou, Han Bai, Xi-Ping Zhao, Xiong Ma, Lan-Juan Li, Zhi-Shui Chen, Yuan-Cheng Huang. Acute Exacerbation of Chronic Hepatitis B2019; : 273 doi: 10.1007/978-94-024-1603-9_4
6
Xin-Yu Liu, Feng Peng, Ya-Jie Pan, Jun Chen. Advanced therapeutic strategies for HBV-related acute-on-chronic liver failureHepatobiliary & Pancreatic Diseases International 2015; 14(4): 354 doi: 10.1016/S1499-3872(15)60338-1
7
Keiichi Fujiwara, Shin Yasui, Yuuki Haga, Masato Nakamura, Yutaka Yonemitsu, Makoto Arai, Tatsuo Kanda, Shigeto Oda, Osamu Yokosuka, Naoya Kato. Early Combination Therapy with Corticosteroid and Nucleoside Analogue Induces Rapid Resolution of Inflammation in Acute Liver Failure due to Transient Hepatitis B Virus InfectionInternal Medicine 2018; 57(11): 1543 doi: 10.2169/internalmedicine.9670-17
8
Keiichi Fujiwara, Shin Yasui, Koichiro Okitsu, Yutaka Yonemitsu, Shigeto Oda, Osamu Yokosuka. The requirement for a sufficient period of corticosteroid treatment in combination with nucleoside analogue for severe acute exacerbation of chronic hepatitis BJournal of Gastroenterology 2010; 45(12): 1255 doi: 10.1007/s00535-010-0280-y
9
Xi Ran, Qiong Fang Zhang, Ling Luo, Da Zhi Zhang, Wei Li. The Efficacy and Safety of Glucocorticoids Plus Conventional Therapy for Hepatitis B-Related Liver Failure in China: A Meta-AnalysisHepatitis Monthly 2019; 19(6) doi: 10.5812/hepatmon.65787
10
Keiichi Fujiwara, Shin Yasui, Yutaka Yonemitsu, Kenichi Fukai, Makoto Arai, Fumio Imazeki, Akihiro Suzuki, Hiroshi Suzuki, Tomohito Sadahiro, Shigeto Oda, Osamu Yokosuka. Efficacy of combination therapy of antiviral and immunosuppressive drugs for the treatment of severe acute exacerbation of chronic hepatitis BJournal of Gastroenterology 2008; 43(9): 711 doi: 10.1007/s00535-008-2222-5
11
Kazuyuki Matsumoto, Yasuhiro Miyake, Hirokazu Miyatake, Masahiro Takahara, Takayuki Imada, Satoru Yagi, Tatsuya Toyokawa, Morihito Nakatsu, Masaharu Ando, Mamoru Hirohata. A combination treatment of entecavir and early-phase corticosteroid in severe exacerbation of chronic hepatitis BWorld Journal of Gastroenterology 2009; 15(13): 1650-1652 doi: 10.3748/wjg.15.1650
12
Xiao Hui Zhang, Ru Feng, Lan Ping Xu, Qian Jiang, Hao Jiang, Hai Xia Fu, Hui Liu, Ting Niu, Xin Wang, Jian Da Hu, Ming Jiang, Zhao Wang, Jing Wen Wang, Hui Ma, Yan Di Xie, Xiao Lu Zhu, Hao Wang, Lai Wei, Xiao-Jun Huang. Immunosuppressive treatment combined with nucleoside analog is superior to nucleoside analog only in the treatment of severe thrombocytopenia in patients with cirrhosis associated with hepatitis B in China: A multicenter, observational studyPlatelets 2015; 26(7): 672 doi: 10.3109/09537104.2014.979339
13
Yong-Tao Han, Chao Sun, Cai-Xia Liu, Shuang-Shuang Xie, Di Xiao, Li Liu, Jin-Hong Yu, Wen-Wen Li, Qiang Li. Clinical features and outcome of acute hepatitis B in pregnancyBMC Infectious Diseases 2014; 14(1) doi: 10.1186/1471-2334-14-368
14
J. P. Allain, S. Owusu-Ofori. Approaches to hepatitis safety in sub-Saharan AfricaISBT Science Series 2006; 1(1): 89 doi: 10.1111/j.1751-2824.2006.00019.x
15
Kyo-Sang Yoo, Kyung-Hun Lee, Kyung Rim Huh, Won Sub Choi, Gang Jeon, Jun-Wook Ha, Kyoung Oh Kim, Cheol Hee Park, Taeho Hahn, Sang Hoon Park, Jong Hyeok Kim, Choong Kee Park. Acute Pancreatitis Complicating Spontaneous Acute Exacerbation of Chronic Hepatitis B Virus Infection: Case Report and Review of the LiteratureGut and Liver 2009; 3(1): 64 doi: 10.5009/gnl.2009.3.1.64
16
Keiichi Fujiwara, Shin Yasui, Akinobu Tawada, Koichiro Okitsu, Yutaka Yonemitsu, Tetsuhiro Chiba, Makoto Arai, Tatsuo Kanda, Fumio Imazeki, Masayuki Nakano, Shigeto Oda, Osamu Yokosuka. Autoimmune fulminant liver failure in adults: Experience in a Japanese centerHepatology Research 2011; 41(2): 133 doi: 10.1111/j.1872-034X.2010.00755.x
17
Makoto Osawa, Yutaka Ito, Toyohiro Hirai, Rie Isozumi, Shunji Takakura, Yasuhiro Fujimoto, Yoshitsugu Iinuma, Satoshi Ichiyama, Koichi Tanaka, Michiaki Mishima. Risk factors for invasive aspergillosis in living donor liver transplant recipientsLiver Transplantation 2007; 13(4): 566 doi: 10.1002/lt.21099
18
Keiichi Fujiwara, Shin Yasui, Osamu Yokosuka. Autoimmune acute liver failure: an emerging etiology for intractable acute liver failureHepatology International 2013; 7(2): 335 doi: 10.1007/s12072-012-9402-3
19
Keiichi Fujiwara, Seiji Hida, Shin Yasui, Osamu Yokosuka, Shigeto Oda. Corticosteroid might reduce serum levels of pro-inflammatory cytokines in fulminant hepatitis: A case seriesHepatology Research 2018; 48(1): 106 doi: 10.1111/hepr.12906
20
S. Yasui, K. Fujiwara, M. Nakamura, T. Miyamura, Y. Yonemitsu, R. Mikata, M. Arai, T. Kanda, F. Imazeki, S. Oda, O. Yokosuka. Virological efficacy of combination therapy with corticosteroid and nucleoside analogue for severe acute exacerbation of chronic hepatitis BJournal of Viral Hepatitis 2015; 22(2): 94 doi: 10.1111/jvh.12258
21
H. Sambatakou, D. W. Denning. Invasive pulmonary aspergillosis transformed into fatal mucous impaction by immune reconstitution in an AIDS patientEuropean Journal of Clinical Microbiology & Infectious Diseases 2005; 24(9): 628 doi: 10.1007/s10096-005-0006-x